🧪Founder uses AI to build a cancer vaccine for his dog

Tech entrepreneur Paul Conyngham created a personalized cancer vaccine after his dog Rosie was diagnosed with aggressive cancer that kept growing despite treatment.

He sequenced Rosie’s DNA and used AI tools to identify cancer mutations. The results went into AlphaEvolve to find protein targets, and researchers at the UNSW RNA Institute turned that analysis into a custom mRNA vaccine.

After injections in late 2025, one of Rosie’s largest tumors shrank by about 50%. Scientists are now preparing a second version of the vaccine to target the remaining tumors.

📊 @tech